Reproductive toxicity profiles of direct-acting antiviral drugs for HCV
YU Chun-rong
DA Hong-yuan
SHAN Xiao-lei
WANG Qing-li
Abstract:With more information available for hepatitis C virus (HCV) study,direct-acting antiviral treatment (DAA) drugs become the main focus area in the treatment of chronic hepatitis C (CHC).In the present review,we summarized the reproductive toxicity profiles of approved DAA drugs based on information from websites of U.S.Food and Drug administration (FDA) in order to enrich the understanding and knowledge of DAA drugs.
Keywords:chronic hepatitis Creproduction toxicity studyantiviral therapydrug research and development
Publication Date:2017-01-01
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:5( 2166-2170 )
